Oliver Thiel

Oliver Thiel

Company: Amgen

Job title: Executive Director Process Development, Drug Substance Technologies Pivotal & Commercial Synthetics


Roundtable Discussion: Sustainable Manufacturing & Novel Green Chemistry Approach 9:45 am

With growing investment in new modalities such as peptides and oligonucleotides, it is increasingly important to tackle the challenges of waste, and sustainable manufacturing. Recognizing the ramifications of formulation and process development, now more than ever we need to turbocharge processes that are less environmentally stressful and move into green chemistryRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.